# Provention Bio, Inc.

Provention Bio, Inc. is a company headquartered in Red Bank, NJ, United States.

## Company overview

- **Legal name:** Provention Bio, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Red Bank, NJ, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001695357

## About

Provention Bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001695357, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-29, it reported annual revenue of USD 12,895,000; net income of USD -113,565,000; total assets of USD 236,856,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $12.9M (USD 12,895,000)
- **Net income:** -$113.6M (USD -113,565,000)
- **Total assets:** $236.9M (USD 236,856,000)
- **Cash and equivalents:** $44.0M (USD 44,039,000)
- **Operating cash flow:** -$75.4M (USD -75,408,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $1.4M (USD 1,395,000)
- **Net income:** -$114.4M (USD -114,432,000)
- **Total assets:** $135.6M (USD 135,621,000)
- **Cash and equivalents:** $78.2M (USD 78,190,000)
- **Operating cash flow:** -$95.4M (USD -95,385,000)

### FY2020 (period ended 2020-12-31)

- **Net income:** -$98.6M (USD -98,581,000)
- **Total assets:** $128.5M (USD 128,519,000)
- **Cash and equivalents:** $102.3M (USD 102,294,000)
- **Operating cash flow:** -$76.3M (USD -76,336,000)

### FY2019 (period ended 2019-12-31)

- **Net income:** -$43.3M (USD -43,285,000)
- **Total assets:** $86.0M (USD 85,996,000)
- **Cash and equivalents:** $39.2M (USD 39,165,000)
- **Operating cash flow:** -$36.1M (USD -36,065,000)

## Recent SEC filings

- Form 8-K — filed 2023-04-27 — period 2023-04-27
- Form 10-K — filed 2023-03-29 — period 2022-12-31
- Form 8-K — filed 2023-03-13 — period 2023-03-13
- Form SC 13G — filed 2023-02-21 — PROVENTION BIO, INC.
- Form 8-K — filed 2023-02-13 — period 2023-02-09
- Form 8-K — filed 2023-02-02 — period 2023-02-02
- Form 8-K — filed 2023-01-05 — period 2023-01-03
- Form 8-K — filed 2022-12-06 — period 2022-11-30
- Form 8-K — filed 2022-11-18 — period 2022-11-17
- Form 10-Q — filed 2022-11-03 — period 2022-09-30
- Form 8-K — filed 2022-11-03 — period 2022-11-03
- Form 8-K — filed 2022-10-06 — period 2022-10-04

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/provention-bio-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology